JP2021507900A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021507900A5 JP2021507900A5 JP2020533765A JP2020533765A JP2021507900A5 JP 2021507900 A5 JP2021507900 A5 JP 2021507900A5 JP 2020533765 A JP2020533765 A JP 2020533765A JP 2020533765 A JP2020533765 A JP 2020533765A JP 2021507900 A5 JP2021507900 A5 JP 2021507900A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- independently
- haloalkyl
- alkoxy
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(C)C(NC(*)=O)=[U] Chemical compound CC(C)C(NC(*)=O)=[U] 0.000 description 5
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762607488P | 2017-12-19 | 2017-12-19 | |
| US62/607,488 | 2017-12-19 | ||
| PCT/US2018/066123 WO2019126094A1 (en) | 2017-12-19 | 2018-12-18 | Cyclohexyl acid triazole azoles as lpa antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021507900A JP2021507900A (ja) | 2021-02-25 |
| JP2021507900A5 true JP2021507900A5 (https=) | 2021-12-16 |
| JP7280881B2 JP7280881B2 (ja) | 2023-05-24 |
Family
ID=65003581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020533765A Active JP7280881B2 (ja) | 2017-12-19 | 2018-12-18 | Ｌｐａアンタゴニストとしてのシクロヘキシル酸トリアゾールアゾール |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US11319315B2 (https=) |
| EP (1) | EP3728224B1 (https=) |
| JP (1) | JP7280881B2 (https=) |
| KR (1) | KR20200100713A (https=) |
| CN (1) | CN111712492B (https=) |
| AR (1) | AR113965A1 (https=) |
| AU (1) | AU2018392325A1 (https=) |
| BR (1) | BR112020012177A2 (https=) |
| CA (1) | CA3085938A1 (https=) |
| EA (1) | EA202091505A1 (https=) |
| ES (1) | ES2938863T3 (https=) |
| IL (1) | IL275363A (https=) |
| MX (1) | MX2020005818A (https=) |
| SG (1) | SG11202005703TA (https=) |
| TW (1) | TW201927778A (https=) |
| WO (1) | WO2019126094A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4011875A1 (en) | 2017-12-19 | 2022-06-15 | Bristol-Myers Squibb Company | Triazole n-linked carbamoyl cyclohexyl acids as lpa antagonists |
| WO2019126089A1 (en) * | 2017-12-19 | 2019-06-27 | Bristol-Myers Squibb Company | Cyclohexyl acid pyrazole azines as lpa antagonists |
| SG11202103731QA (en) * | 2018-10-15 | 2021-05-28 | Bristol Myers Squibb Co | Radioligands for imaging the lpa1 receptor |
| CN111434653A (zh) | 2019-01-15 | 2020-07-21 | 武汉朗来科技发展有限公司 | 三氮唑类化合物及其制备方法与用途 |
| EP3986553B1 (en) | 2019-06-18 | 2026-03-25 | Bristol-Myers Squibb Company | Cyclobutyl carboxylic acids as lpa antagonists |
| AU2020384883B2 (en) | 2019-11-15 | 2023-11-16 | Gilead Sciences, Inc. | Triazole carbamate pyridyl sulfonamides as LPA receptor antagonists and uses thereof |
| TWI843503B (zh) | 2020-06-03 | 2024-05-21 | 美商基利科學股份有限公司 | Lpa受體拮抗劑及其用途 |
| CN115867556B (zh) | 2020-06-03 | 2025-05-06 | 吉利德科学公司 | Lpa受体拮抗剂及其用途 |
| EP4196220A1 (en) * | 2020-08-11 | 2023-06-21 | Viva Star Biosciences Limited | Triazole-pyridinyl substituted azacyclohexyl acetic acid compounds as lpa receptor antagonists |
| EP4670791A3 (en) * | 2020-10-22 | 2026-03-04 | Lhotse Bio, Inc. | Compounds and compositions for treating conditions associated with lpa receptor activity |
| CN114621135B (zh) * | 2020-12-11 | 2024-01-30 | 上海拓界生物医药科技有限公司 | 一种lpa1小分子拮抗剂 |
| TWI853704B (zh) | 2021-05-11 | 2024-08-21 | 美商基利科學股份有限公司 | Lpa受體拮抗劑及其用途 |
| KR20240007233A (ko) | 2021-05-13 | 2024-01-16 | 길리애드 사이언시즈, 인코포레이티드 | Lpa 수용체 길항제 및 이의 용도 |
| AU2022327398A1 (en) * | 2021-08-12 | 2024-03-21 | Shanghai SIMR Biotechnology Co., Ltd | Substituted triazole derivative, preparation method therefor, pharmaceutical composition thereof, and use thereof |
| WO2023107938A1 (en) | 2021-12-08 | 2023-06-15 | Gilead Sciences, Inc. | Lpa receptor antagonists and uses thereof |
| AR128613A1 (es) | 2022-02-25 | 2024-05-29 | Lhotse Bio Inc | Compuestos y composiciones para el tratamiento de afecciones asociadas con la actividad del receptor de lpa |
| CN115785014B (zh) * | 2022-12-27 | 2025-01-24 | 瑞石生物医药有限公司 | 四唑衍生物及其用途 |
| US12359594B2 (en) | 2023-08-01 | 2025-07-15 | Discovery Energy, Llc | Convertible silencer |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002062389A1 (en) | 2001-02-08 | 2002-08-15 | Ono Pharmaceutical Co., Ltd. | Remedies for urinary diseases comprising lpa receptor controlling agents |
| DE102004038403B4 (de) | 2004-08-07 | 2006-08-31 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 3-Hydroxycyclohexancarbonsäure-Derivaten |
| US20080186971A1 (en) | 2007-02-02 | 2008-08-07 | Tarari, Inc. | Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic |
| MX2010010877A (es) | 2008-04-04 | 2010-10-26 | Irm Llc | Compuestos y composiciones como inhibidores de itpkb. |
| WO2011017350A2 (en) | 2009-08-04 | 2011-02-10 | Amira Pharmaceuticals, Inc. | Compounds as lysophosphatidic acid receptor antagonists |
| GB2474120B (en) | 2009-10-01 | 2011-12-21 | Amira Pharmaceuticals Inc | Compounds as Lysophosphatidic acid receptor antagonists |
| GB2474748B (en) | 2009-10-01 | 2011-10-12 | Amira Pharmaceuticals Inc | Polycyclic compounds as lysophosphatidic acid receptor antagonists |
| EA201390821A1 (ru) | 2010-12-07 | 2013-10-30 | Амира Фармасьютикалс, Инк. | Антагонисты рецепторов лизофосфатидной кислоты и их применение |
| US8785442B2 (en) | 2011-01-30 | 2014-07-22 | Curegenix, Inc. | Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof |
| EP2694472B1 (en) | 2011-04-05 | 2020-03-11 | Takeda Pharmaceutical Company Limited | Sulfonamide derivative and use thereof |
| WO2012138648A1 (en) | 2011-04-06 | 2012-10-11 | Irm Llc | Compositions and methods for modulating lpa receptors |
| US9586963B2 (en) | 2011-09-27 | 2017-03-07 | Genfit | Derivatives of 6-substituted triazolopyridazines as Rev-Erb agonists |
| WO2013070879A1 (en) | 2011-11-10 | 2013-05-16 | Bristol-Myers Squibb Company | Methods for treating spinal cord injury with lpa receptor antagonists |
| US20140329871A1 (en) | 2011-12-04 | 2014-11-06 | Angion Biomedica Corp. | Small molecule anti-fibrotic compounds and uses thereof |
| US9187474B2 (en) | 2012-03-07 | 2015-11-17 | Deciphera Pharmaceuticals, Llc | Raf inhibitor compounds |
| SG11201407228PA (en) | 2012-06-20 | 2014-12-30 | Hoffmann La Roche | N-aryltriazole compounds as lpar antagonists |
| UA109868C2 (ru) | 2012-06-20 | 2015-10-12 | Ф. Хоффманн-Ля Рош Аг | Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar) |
| JP6853619B2 (ja) | 2015-01-16 | 2021-03-31 | 大塚製薬株式会社 | シアノトリアゾール化合物の医薬用途 |
| AR108838A1 (es) | 2016-06-21 | 2018-10-03 | Bristol Myers Squibb Co | Ácidos de carbamoiloximetil triazol ciclohexilo como antagonistas de lpa |
| EP4011875A1 (en) | 2017-12-19 | 2022-06-15 | Bristol-Myers Squibb Company | Triazole n-linked carbamoyl cyclohexyl acids as lpa antagonists |
-
2018
- 2018-12-18 EA EA202091505A patent/EA202091505A1/ru unknown
- 2018-12-18 WO PCT/US2018/066123 patent/WO2019126094A1/en not_active Ceased
- 2018-12-18 US US16/772,842 patent/US11319315B2/en active Active
- 2018-12-18 TW TW107145552A patent/TW201927778A/zh unknown
- 2018-12-18 MX MX2020005818A patent/MX2020005818A/es unknown
- 2018-12-18 CN CN201880089521.5A patent/CN111712492B/zh active Active
- 2018-12-18 SG SG11202005703TA patent/SG11202005703TA/en unknown
- 2018-12-18 AR ARP180103701A patent/AR113965A1/es unknown
- 2018-12-18 BR BR112020012177-0A patent/BR112020012177A2/pt not_active Application Discontinuation
- 2018-12-18 EP EP18830682.3A patent/EP3728224B1/en active Active
- 2018-12-18 AU AU2018392325A patent/AU2018392325A1/en not_active Abandoned
- 2018-12-18 CA CA3085938A patent/CA3085938A1/en not_active Abandoned
- 2018-12-18 JP JP2020533765A patent/JP7280881B2/ja active Active
- 2018-12-18 ES ES18830682T patent/ES2938863T3/es active Active
- 2018-12-18 KR KR1020207020532A patent/KR20200100713A/ko not_active Withdrawn
-
2020
- 2020-06-14 IL IL275363A patent/IL275363A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021507900A5 (https=) | ||
| JP2021508686A5 (https=) | ||
| JP2021506878A5 (https=) | ||
| JPWO2019126086A5 (https=) | ||
| JP2019094345A5 (https=) | ||
| JP6147761B2 (ja) | アミノ置換イミダゾピリダジン | |
| JP2022507888A (ja) | 短鎖デヒドロゲナーゼ活性を調節する組成物及び方法 | |
| JP2019514903A5 (https=) | ||
| JP2021507895A5 (https=) | ||
| JP2016523973A5 (https=) | ||
| JP6783756B2 (ja) | ｍＩＤＨ１阻害剤としてのベンゾイミダゾール−２−アミン | |
| KR20110082569A (ko) | Ｈｉｆ 억제제로서의 헤테로시클릭 치환된 아릴 화합물 | |
| WO2017121684A1 (en) | 5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines | |
| JP6672288B2 (ja) | 腫瘍の治療のためのｍｉｄｈ１阻害剤としての１−シクロヘキシル−２−フェニルアミノベンゾイミダゾール | |
| JP2017537948A5 (https=) | ||
| RU2006134020A (ru) | Конденсированные производные пиразола | |
| JP2013545776A (ja) | 過剰増殖性障害の治療におけるｍｐｓ−１およびｔｋｋ阻害剤として使用するための６置換イミダゾピラジン | |
| JP2015511617A (ja) | アミノ置換イミダゾピリダジン | |
| JP2017512786A5 (https=) | ||
| KR20110082570A (ko) | Ｈｉｆ 억제제로서 사용하기 위한 헤테로방향족 화합물 | |
| JP2020504716A5 (https=) | ||
| JPWO2020060915A5 (https=) | ||
| JP2018515623A5 (https=) | ||
| JP2007508238A5 (https=) | ||
| JPWO2019126085A5 (https=) |